Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graeme Bilbe

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Science (New York, N.Y.)|May 30, 2015
Infectious diseases. Overcoming neglect of kinetoplastid diseasesGraeme Bilbe
Journal of Neurochemistry|July 16, 2003
Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal poleAnu K Kinnunen, James I Koenig, Graeme Bilbe
Current Opinion in Drug Discovery & Development|August 30, 2008
mGluR5 antagonists: discovery, characterization and drug developmentFabrizio Gasparini, Graeme Bilbe, Baltazar Gomez-Mancilla, et al.
Schizophrenia Bulletin|June 15, 2005
At issue: A model for academic/industry collaborationWilliam T Carpenter, James I Koenig, Graeme Bilbe, et al.
Pharmacology & Therapeutics|October 27, 2007
Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosisKumlesh K Dev, Florian Mullershausen, Henri Mattes, et al.
Genome Research|April 3, 2004
Applications of a rat multiple tissue gene expression data setJohn R Walker, Andrew I Su, David W Self, et al.
Bioorganic & Medicinal Chemistry|October 16, 2014
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterizationIvo Vranesic, Silvio Ofner, Peter Josef Flor, et al.
Parkinsonism & Related Disorders|February 15, 2011
The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeysLaurent Grégoire, Nicolas Morin, Bazoumana Ouattara, et al.
Neuropharmacology|September 17, 2008
The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and painDominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe, et al.
Plos Currents|February 1, 2011
Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington DiseaseMiriam Moscovitch-Lopatin, Andreas Weiss, Herminia Diana Rosas, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Science (New York, N.Y.)|May 30, 2015
Infectious diseases. Overcoming neglect of kinetoplastid diseasesGraeme Bilbe
Journal of Neurochemistry|July 16, 2003
Repeated variable prenatal stress alters pre- and postsynaptic gene expression in the rat frontal poleAnu K Kinnunen, James I Koenig, Graeme Bilbe
Current Opinion in Drug Discovery & Development|August 30, 2008
mGluR5 antagonists: discovery, characterization and drug developmentFabrizio Gasparini, Graeme Bilbe, Baltazar Gomez-Mancilla, et al.
Schizophrenia Bulletin|June 15, 2005
At issue: A model for academic/industry collaborationWilliam T Carpenter, James I Koenig, Graeme Bilbe, et al.
Pharmacology & Therapeutics|October 27, 2007
Brain sphingosine-1-phosphate receptors: implication for FTY720 in the treatment of multiple sclerosisKumlesh K Dev, Florian Mullershausen, Henri Mattes, et al.
Genome Research|April 3, 2004
Applications of a rat multiple tissue gene expression data setJohn R Walker, Andrew I Su, David W Self, et al.
Bioorganic & Medicinal Chemistry|October 16, 2014
AFQ056/mavoglurant, a novel clinically effective mGluR5 antagonist: identification, SAR and pharmacological characterizationIvo Vranesic, Silvio Ofner, Peter Josef Flor, et al.
Parkinsonism & Related Disorders|February 15, 2011
The acute antiparkinsonian and antidyskinetic effect of AFQ056, a novel metabotropic glutamate receptor type 5 antagonist, in L-Dopa-treated parkinsonian monkeysLaurent Grégoire, Nicolas Morin, Bazoumana Ouattara, et al.
Neuropharmacology|September 17, 2008
The selective nicotinic acetylcholine receptor alpha7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and painDominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe, et al.
Plos Currents|February 1, 2011
Optimization of an HTRF Assay for the Detection of Soluble Mutant Huntingtin in Human Buffy Coats: A Potential Biomarker in Blood for Huntington DiseaseMiriam Moscovitch-Lopatin, Andreas Weiss, Herminia Diana Rosas, et al.
Pageof 3